Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Cooper

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Clinical Endocrinology|August 28, 2022
Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidusHiroshi Arima, Timothy Cheetham, Mirjam Christ-Crain, et al.
The Journal of Clinical Endocrinology and Metabolism|November 10, 2022
Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes InsipidusHiroshi Arima, Timothy Cheetham, Mirjam Christ-Crain, et al.
International Journal of Mental Health Systems|August 19, 2025
Suicide among youth and young adults in Canada: bereaved parents' perspectives on the systems of careToula Kourgiantakis, Deborah Cooper, David Cooper, et al.
Annals of Neurology|June 4, 2014
Loss of dopamine phenotype among midbrain neurons in Lesch-Nyhan diseaseMartin Göttle, Cecilia N Prudente, Rong Fu, et al.
European Journal of Endocrinology|October 14, 2022
Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus, Hiroshi Arima, Timothy Cheetham, et al.
Journal of Natural Products|January 24, 2004
Ponicidin and oridonin are responsible for the antiangiogenic activity of Rabdosia rubescens, a constituent of the herbal supplement PC SPESLinda C Meade-Tollin, E M Kithsiri Wijeratne, Deborah Cooper, et al.
Pituitary|November 5, 2022
Changing the name of diabetes insipidusHiroshi Arima, Daniel G Bichet, Timothy Cheetham, et al.
Endocrine Connections|October 13, 2022
Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus, Hiroshi Arima, Timothy Cheetham, et al.
Endocrine Journal|October 16, 2022
Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus, Hiroshi Arima, Timothy Cheetham, et al.
Trials|July 8, 2022
Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary careSarah L Alderson, Alexandra Wright-Hughes, Alexander C Ford, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Clinical Endocrinology|August 28, 2022
Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidusHiroshi Arima, Timothy Cheetham, Mirjam Christ-Crain, et al.
The Journal of Clinical Endocrinology and Metabolism|November 10, 2022
Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes InsipidusHiroshi Arima, Timothy Cheetham, Mirjam Christ-Crain, et al.
International Journal of Mental Health Systems|August 19, 2025
Suicide among youth and young adults in Canada: bereaved parents' perspectives on the systems of careToula Kourgiantakis, Deborah Cooper, David Cooper, et al.
Annals of Neurology|June 4, 2014
Loss of dopamine phenotype among midbrain neurons in Lesch-Nyhan diseaseMartin Göttle, Cecilia N Prudente, Rong Fu, et al.
European Journal of Endocrinology|October 14, 2022
Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus, Hiroshi Arima, Timothy Cheetham, et al.
Journal of Natural Products|January 24, 2004
Ponicidin and oridonin are responsible for the antiangiogenic activity of Rabdosia rubescens, a constituent of the herbal supplement PC SPESLinda C Meade-Tollin, E M Kithsiri Wijeratne, Deborah Cooper, et al.
Pituitary|November 5, 2022
Changing the name of diabetes insipidusHiroshi Arima, Daniel G Bichet, Timothy Cheetham, et al.
Endocrine Connections|October 13, 2022
Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus, Hiroshi Arima, Timothy Cheetham, et al.
Endocrine Journal|October 16, 2022
Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus, Hiroshi Arima, Timothy Cheetham, et al.
Trials|July 8, 2022
Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary careSarah L Alderson, Alexandra Wright-Hughes, Alexander C Ford, et al.
Pageof 4